Sarcoma, Endometrial Stromal - 20 Studies Found
Completed |
: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 :
: 2014-05-15 :
|
Completed |
: Mifepristone for Patients With Endometrial Cancer and LGESS : Endometrial Cancer : 2007-07-19 : Drug: Mifepristone 200 mg by mouth (PO) Daily x 4 Weeks |
Not yet recruiting |
: A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma :
: |
Completed |
: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer :
|
Completed |
: Collecting Tumor Samples From Patients With Gynecological Tumors :
: 2000-05-02 : Drug: pegylated liposomal doxorubicin hydrochloride |
Completed |
: Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus :
: 1999-11-01 : Radiation: radiation therapy |
Completed |
: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases : Life Threatening Diseases : 2005-09-09 : Drug: Imatinib mesylate |
Terminated |
: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer : Cancer : 2010-05-26 :
|